Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Curr Opin Immunol. 2021 Jun 23;72:196–205. doi: 10.1016/j.coi.2021.06.006

Figure 1.

Figure 1.

IFNAR1 and IFNAR2 expression and dynamics in health and Down syndrome. Diagram of transcription, translation and surface expression of the IFN-I receptor (right) and its trafficking after signaling resulting in lysosomal degradation of IFNAR1 and recycling of IFNAR2 (left). Blue boxes denote alterations characterized in Down syndrome.